Centene Corp (CNC) stock
CNCNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 8/301% above fair value
$70.27−0.21 (-0.30%)
Close on Nov 12, 2026Market cap $34.79BP/E 24.1Yield –
Centene ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Centene's ebitda for the twelve months ending Sep 30, 2026 was $2.24B. For fiscal 2025 it was -$6.35B, down 243.8% from the year before. The highest annual figure on record is $4.42B in fiscal 2024.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$6.35B | -243.8% |
| FY2024 | Dec 31, 2024 | $4.42B | +4.6% |
| FY2023 | Dec 31, 2023 | $4.22B | +53.7% |
| FY2022 | Dec 31, 2022 | $2.75B | -11.9% |
| FY2021 | Dec 31, 2021 | $3.12B | -28.2% |
| FY2020 | Dec 31, 2020 | $4.34B | +79.1% |
| FY2019 | Dec 31, 2019 | $2.42B | +24.1% |
| FY2018 | Dec 31, 2018 | $1.95B | +25.2% |
| FY2017 | Dec 31, 2017 | $1.56B | +1.2% |
| FY2016 | Dec 31, 2016 | $1.54B | +88.8% |
| FY2015 | Dec 31, 2015 | $816.00M | +47.6% |
| FY2014 | Dec 31, 2014 | $553.00M | +60.8% |
| FY2013 | Dec 31, 2013 | $344.00M | +97.7% |
| FY2012 | Dec 31, 2012 | $174.00M | -33.6% |
| FY2011 | Dec 31, 2011 | $262.13M | +25.4% |
| FY2010 | Dec 31, 2010 | $209.07M | +14.8% |
| FY2009 | Dec 31, 2009 | $182.14M | +9.1% |
| FY2008 | Dec 31, 2008 | $166.98M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$8.00M | – |
| Q2 FY2026 | Jun 30, 2026 | $1.50B | – |
| Q1 FY2026 | Mar 31, 2026 | $2.16B | +16.9% |
| Q4 FY2025 | Dec 31, 2025 | -$1.42B | -389.6% |
| Q3 FY2025 | Sep 30, 2025 | -$6.64B | -778.6% |
| Q2 FY2025 | Jun 30, 2025 | -$143.00M | -109.3% |
| Q1 FY2025 | Mar 31, 2025 | $1.85B | +30.7% |
| Q4 FY2024 | Dec 31, 2024 | $489.00M | +304.1% |
| Q3 FY2024 | Sep 30, 2024 | $978.00M | -8.0% |
| Q2 FY2024 | Jun 30, 2024 | $1.54B | +2.6% |
| Q1 FY2024 | Mar 31, 2024 | $1.41B | -8.4% |
| Q4 FY2023 | Dec 31, 2023 | $121.00M | +75.4% |
| Q3 FY2023 | Sep 30, 2023 | $1.06B | +27.0% |
| Q2 FY2023 | Jun 30, 2023 | $1.50B | +651.8% |
| Q1 FY2023 | Mar 31, 2023 | $1.54B | -6.1% |
| Q4 FY2022 | Dec 31, 2022 | $69.00M | -91.8% |
| Q3 FY2022 | Sep 30, 2022 | $837.00M | -9.6% |
| Q2 FY2022 | Jun 30, 2022 | $199.00M | – |
| Q1 FY2022 | Mar 31, 2022 | $1.64B | +16.1% |
| Q4 FY2021 | Dec 31, 2021 | $840.00M | +134.6% |
| Q3 FY2021 | Sep 30, 2021 | $926.00M | -20.1% |
| Q2 FY2021 | Jun 30, 2021 | -$62.00M | -102.6% |
| Q1 FY2021 | Mar 31, 2021 | $1.42B | +197.3% |
| Q4 FY2020 | Dec 31, 2020 | $358.00M | -19.6% |
| Q3 FY2020 | Sep 30, 2020 | $1.16B | +242.9% |
| Q2 FY2020 | Jun 30, 2020 | $2.35B | +193.1% |
| Q1 FY2020 | Mar 31, 2020 | $476.00M | -43.3% |
| Q4 FY2019 | Dec 31, 2019 | $445.00M | -15.9% |
| Q3 FY2019 | Sep 30, 2019 | $338.00M | +87.8% |
| Q2 FY2019 | Jun 30, 2019 | $801.00M | +33.5% |
| Q1 FY2019 | Mar 31, 2019 | $840.00M | +30.4% |
| Q4 FY2018 | Dec 31, 2018 | $529.00M | +90.3% |
| Q3 FY2018 | Sep 30, 2018 | $180.00M | -58.2% |
| Q2 FY2018 | Jun 30, 2018 | $600.00M | +14.3% |
| Q1 FY2018 | Mar 31, 2018 | $644.00M | +97.5% |
| Q4 FY2017 | Dec 31, 2017 | $278.00M | -54.6% |
| Q3 FY2017 | Sep 30, 2017 | $431.00M | – |
| Q2 FY2017 | Jun 30, 2017 | $525.00M | – |
| Q1 FY2017 | Mar 31, 2017 | $326.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $613.00M | – |
See a number that looks wrong?